Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dose-dependent decrease of activation in bilateral amygdala and insula by lorazepam during emotion processing.

Martin P Paulus1, Justin S Feinstein, Gabriel Castillo

  • 1Laboratory of Biological Dynamics and Theoretical Medicine and Department of Psychiatry, University of California, San Diego, USA.

Archives of General Psychiatry
|March 9, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Empathy motivation is preserved following amygdala damage.

Brain : a journal of neurology·2026
Same author

The association between childhood maltreatment and neural functioning during a working memory task in adults with internalizing disorders.

Brain imaging and behavior·2026
Same author

Pretraining neural and neuropsychological measures of executive functioning are associated with response to working memory training in Veterans with PTSD.

Psychological medicine·2026
Same author

Brain mechanisms of pain anticipation in chronic low back pain: Insights into phenotypical responses to mind-body therapy.

The journal of pain·2026
Same author

Longitudinal Study of Sexual Dysfunction in Men and Women with Inflammatory Bowel Disease Initiating Biologic or Small Molecule Therapy.

Digestive diseases and sciences·2026
Same author

Opioid Craving in Chronic Pain Management: A Structural Equation Model of Veterans in Pain Rehabilitation.

Military medicine·2025
Same journal

Reviewers Who Completed a Review During 2011.

Archives of general psychiatry·2017
Same journal

Conflicts of interest-reply.

Archives of general psychiatry·2013
Same journal

Epidemiologic evidence concerning the bereavement exclusion in major depression-reply.

Archives of general psychiatry·2013
Same journal

This month in archives of general psychiatry.

Archives of general psychiatry·2013
Same journal

About this journal.

Archives of general psychiatry·2013
Same journal

This month in archives of general psychiatry.

Archives of general psychiatry·2013
See all related articles

This study shows that lorazepam reduces brain activity in the amygdala and insula in a dose-dependent manner, as measured by functional MRI (fMRI). This provides neuroimaging evidence for how anxiety medications work.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Medical Imaging

Background:

  • Anxiety disorders are linked to amygdala and limbic system dysfunction.
  • Functional neuroimaging can reveal anxiety pathophysiology and drug mechanisms.
  • The amygdala is a key target for anxiolytic drug development.

Purpose of the Study:

  • To investigate if lorazepam dose-dependently reduces BOLD fMRI activation in the amygdala and related areas.
  • To assess the drug's effect during an emotion face assessment task.

Main Methods:

  • A double-blind, placebo-controlled, randomized study with 15 healthy volunteers.
  • Subjects received placebo, 0.25 mg, or 1.0 mg lorazepam before fMRI.
  • Blood oxygenation level-dependent (BOLD) fMRI measured brain activity during an emotion face task.

Related Experiment Videos

Main Results:

  • Lorazepam significantly decreased BOLD fMRI signal in the amygdala and insula dose-dependently.
  • No significant effect was observed in the medial prefrontal cortex or primary visual cortex.
  • These findings suggest lorazepam modulates limbic activity related to anxiety processing.

Conclusions:

  • This study provides the first neuroimaging evidence of lorazepam's dose-dependent effects on brain regions critical for anxiety.
  • BOLD fMRI with pharmacological probes can investigate neural circuits of anxiety.
  • fMRI is a valuable tool for developing new anxiolytic medications.